you are here: Home News Venus Remedies

Venus Remedies

Venus Remedies Consolidated September 2025 Net Sales at Rs 192.75 crore, up 15.11% Y-o-Y
Venus Remedies Standalone September 2025 Net Sales at Rs 192.65 crore, up 15.35% Y-o-Y
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
Stocks to Watch Today: MCX India, Oberoi Realty, Cipla, Venus Remedies, Dixon Technologies, L&T Finance in focus on 21 January
Venus Remedies shares rise 3% as Moldova GMP nod paves way for East Europe expansion
Venus Remedies bags Marketing Authorization in the Philippines for Chemotherapy agent
Venus Remedies Consolidated September 2024 Net Sales at Rs 167.45 crore, down 0.16% Y-o-Y
Venus Remedies Standalone September 2024 Net Sales at Rs 167.02 crore, down 1.86% Y-o-Y
Venus Remedies Consolidated June 2024 Net Sales at Rs 108.61 crore, up 14.15% Y-o-Y
Venus Remedies Standalone June 2024 Net Sales at Rs 105.86 crore, up 7.33% Y-o-Y
Venus Remedies Consolidated March 2024 Net Sales at Rs 195.16 crore, up 25.39% Y-o-Y
Venus Remedies Standalone March 2024 Net Sales at Rs 175.16 crore, up 17.93% Y-o-Y
Venus Remedies gets marketing authorisations for three cancer drugs from Ukraine
Venus Remedies Consolidated December 2023 Net Sales at Rs 143.42 crore, up 22.69% Y-o-Y
Venus Remedies Standalone December 2023 Net Sales at Rs 131.23 crore, up 19.9% Y-o-Y
Venus Remedies Standalone September 2023 Net Sales at Rs 170.19 crore, up 36.42% Y-o-Y
Venus Remedies gets UK approval for chemotherapy drugs
Venus Remedies gets marketing approval for six chemotherapy drugs from Philippines
Venus Remedies gains 4% on Philippine nod to market 6 chemotherapy drugs
Venus Remedies trades 2% up on approval to market cancer drugs in Serbia
Venus Remedies gains on registering with govt body; to get custom duty exemption
Venus Remedies gets marketing approval for anticoagulant drug in Saudi Arabia

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Venus Remedies

Venus Remedies Consolidated September 2025 Net Sales at Rs 192.75 crore, up 15.11% Y-o-Y

Venus Remedies Standalone September 2025 Net Sales at Rs 192.65 crore, up 15.35% Y-o-Y

Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y

Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y

Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y

Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y

Stocks to Watch Today: MCX India, Oberoi Realty, Cipla, Venus Remedies, Dixon Technologies, L&T Finance in focus on 21 January

Venus Remedies shares rise 3% as Moldova GMP nod paves way for East Europe expansion

Venus Remedies bags Marketing Authorization in the Philippines for Chemotherapy agent

Venus Remedies Consolidated September 2024 Net Sales at Rs 167.45 crore, down 0.16% Y-o-Y

Venus Remedies Standalone September 2024 Net Sales at Rs 167.02 crore, down 1.86% Y-o-Y

Venus Remedies Consolidated June 2024 Net Sales at Rs 108.61 crore, up 14.15% Y-o-Y

Venus Remedies Standalone June 2024 Net Sales at Rs 105.86 crore, up 7.33% Y-o-Y

Venus Remedies Consolidated March 2024 Net Sales at Rs 195.16 crore, up 25.39% Y-o-Y

Venus Remedies Standalone March 2024 Net Sales at Rs 175.16 crore, up 17.93% Y-o-Y

Venus Remedies gets marketing authorisations for three cancer drugs from Ukraine

Venus Remedies Consolidated December 2023 Net Sales at Rs 143.42 crore, up 22.69% Y-o-Y

Venus Remedies Standalone December 2023 Net Sales at Rs 131.23 crore, up 19.9% Y-o-Y

Venus Remedies Standalone September 2023 Net Sales at Rs 170.19 crore, up 36.42% Y-o-Y

Venus Remedies gets UK approval for chemotherapy drugs

Venus Remedies gets marketing approval for six chemotherapy drugs from Philippines

Venus Remedies gains 4% on Philippine nod to market 6 chemotherapy drugs

Venus Remedies trades 2% up on approval to market cancer drugs in Serbia

Venus Remedies gains on registering with govt body; to get custom duty exemption

Venus Remedies gets marketing approval for anticoagulant drug in Saudi Arabia